YolTech Announces Licensing Agreement with Salubris for the Development and Commercialization of YOLT-101 in Mainland China ...Middle East

PR Newswire - News
YolTech Announces Licensing Agreement with Salubris for the Development and Commercialization of YOLT-101 in Mainland China
SHANGHAI, Aug. 27, 2024 /PRNewswire/ -- YolTech Therapeutics, a pioneering clinical-stage gene editing company dedicated to delivering lifelong cures, announced today that it has entered into an exclusive licensing agreement with Salubris Pharmaceuticals Co., Ltd. (stock code: 002294.SZ),...

Hence then, the article about yoltech announces licensing agreement with salubris for the development and commercialization of yolt 101 in mainland china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( YolTech Announces Licensing Agreement with Salubris for the Development and Commercialization of YOLT-101 in Mainland China )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News